vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and OLYMPIC STEEL INC (ZEUS). Click either name above to swap in a different company.
OLYMPIC STEEL INC is the larger business by last-quarter revenue ($490.7M vs $263.6M, roughly 1.9× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 0.4%, a 14.4% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs 4.4%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs 0.1%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Olympic Steel, Inc. is a metals service center based in Cleveland, Ohio. The company processes and distributes carbon, coated and stainless flat-rolled sheet, coil and plate steel, aluminium alloy, tin plate, and metal-intensive branded products primarily in the United States. Metals processing and value added services include tempering, stretch leveling, cutting-to-length, slitting, edging, shearing, blanking, burning, forming, shot blasting, laser punching, plate rolling, fabricating, machi...
BCPC vs ZEUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $490.7M |
| Net Profit | $39.2M | $2.2M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | 1.5% |
| Net Margin | 14.9% | 0.4% |
| Revenue YoY | 9.8% | 4.4% |
| Net Profit YoY | 16.8% | -21.2% |
| EPS (diluted) | $1.21 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | — | ||
| Q3 25 | $267.6M | $490.7M | ||
| Q2 25 | $255.5M | $496.5M | ||
| Q1 25 | $250.5M | $492.9M | ||
| Q4 24 | $240.0M | $418.8M | ||
| Q3 24 | $239.9M | $470.0M | ||
| Q2 24 | $234.1M | $526.3M | ||
| Q1 24 | $239.7M | $526.6M |
| Q4 25 | $39.2M | — | ||
| Q3 25 | $40.3M | $2.2M | ||
| Q2 25 | $38.3M | $5.2M | ||
| Q1 25 | $37.1M | $2.5M | ||
| Q4 24 | $33.6M | $3.9M | ||
| Q3 24 | $33.8M | $2.7M | ||
| Q2 24 | $32.1M | $7.7M | ||
| Q1 24 | $29.0M | $8.7M |
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | 1.5% | ||
| Q2 25 | 20.1% | 2.3% | ||
| Q1 25 | 20.4% | 1.6% | ||
| Q4 24 | 19.8% | 2.1% | ||
| Q3 24 | 20.0% | 1.7% | ||
| Q2 24 | 19.6% | 2.9% | ||
| Q1 24 | 17.4% | 3.0% |
| Q4 25 | 14.9% | — | ||
| Q3 25 | 15.1% | 0.4% | ||
| Q2 25 | 15.0% | 1.1% | ||
| Q1 25 | 14.8% | 0.5% | ||
| Q4 24 | 14.0% | 0.9% | ||
| Q3 24 | 14.1% | 0.6% | ||
| Q2 24 | 13.7% | 1.5% | ||
| Q1 24 | 12.1% | 1.7% |
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | $0.18 | ||
| Q2 25 | $1.17 | $0.45 | ||
| Q1 25 | $1.13 | $0.21 | ||
| Q4 24 | $1.03 | $0.33 | ||
| Q3 24 | $1.03 | $0.23 | ||
| Q2 24 | $0.98 | $0.66 | ||
| Q1 24 | $0.89 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $7.5M |
| Total DebtLower is stronger | — | $240.9M |
| Stockholders' EquityBook value | $1.3B | $579.1M |
| Total Assets | $1.7B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | $7.5M | ||
| Q2 25 | $65.4M | $14.8M | ||
| Q1 25 | $49.9M | $13.3M | ||
| Q4 24 | $49.5M | $11.9M | ||
| Q3 24 | $73.7M | $11.1M | ||
| Q2 24 | $63.7M | $9.4M | ||
| Q1 24 | $60.3M | $10.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | $240.9M | ||
| Q2 25 | — | $233.2M | ||
| Q1 25 | — | $235.4M | ||
| Q4 24 | — | $272.5M | ||
| Q3 24 | — | $197.3M | ||
| Q2 24 | — | $209.2M | ||
| Q1 24 | — | $196.8M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $579.1M | ||
| Q2 25 | $1.3B | $578.2M | ||
| Q1 25 | $1.2B | $574.2M | ||
| Q4 24 | $1.1B | $573.9M | ||
| Q3 24 | $1.2B | $570.6M | ||
| Q2 24 | $1.1B | $569.5M | ||
| Q1 24 | $1.1B | $563.0M |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.6B | $1.0B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $1.0B | ||
| Q1 24 | $1.6B | $1.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.41× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $-5.4M |
| Free Cash FlowOCF − Capex | — | $-12.9M |
| FCF MarginFCF / Revenue | — | -2.6% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 1.72× | -2.50× |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | — | ||
| Q3 25 | $65.6M | $-5.4M | ||
| Q2 25 | $47.3M | $15.5M | ||
| Q1 25 | $36.5M | $49.4M | ||
| Q4 24 | $52.3M | $14.6M | ||
| Q3 24 | $51.3M | $24.6M | ||
| Q2 24 | $45.0M | $-2.9M | ||
| Q1 24 | $33.4M | $-2.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-12.9M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $40.6M | ||
| Q4 24 | — | $7.4M | ||
| Q3 24 | — | $15.6M | ||
| Q2 24 | — | $-11.3M | ||
| Q1 24 | — | $-7.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | -2.6% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | -2.2% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | -2.50× | ||
| Q2 25 | 1.23× | 2.96× | ||
| Q1 25 | 0.98× | 19.70× | ||
| Q4 24 | 1.56× | 3.75× | ||
| Q3 24 | 1.52× | 9.01× | ||
| Q2 24 | 1.40× | -0.38× | ||
| Q1 24 | 1.15× | -0.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
ZEUS
| Carbon Flat Products | $268.2M | 55% |
| Specialty Metals Flat Products | $140.9M | 29% |
| Tubular And Pipe Products | $81.6M | 17% |
